NCT03141073View on ClinicalTrials.gov

Long-term Efficacy and Safety of HMS5552 add-on to Metformin in T2DM Subjects

PHASE3CompletedINTERVENTIONAL
Enrollment

767

Participants

Timeline

Start Date

October 15, 2017

Primary Completion Date

February 28, 2021

Study Completion Date

February 28, 2021

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

HMS5552

BID oral administration

DRUG

Placebo

BID oral administration

Trial Locations (1)

Unknown

Hua Medicine Limited, Shanghai

Sponsors

Collaborators (1)

Covance
All Listed Sponsors
collaborator

Covance

INDUSTRY

lead

Hua Medicine Limited

INDUSTRY